Security record · archived quarter
RZLT
Rezolute, Inc. · Healthcare · Biotechnology
10Tracked holders
0Δ holders
26.66MShares held
$118.90MReported value
+2New positions
−2Exits
Momentum inputs (comparable managers): holder breadth 0.0% · share flow +7.5% · net new positions 0.0% — formula
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q2 2025
Ownership over time
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q2 2026 | 64 | +3 | 50.24M | $261.09M | +9 | −6 |
| Q1 2026 | 63 | +7 | 53.20M | $162.23M | +14 | −7 |
| Q4 2025 | 56 | +1 | 61.70M | $145.62M | +3 | −2 |
| Q3 2025 | 14 | +1 | 31.48M | $295.95M | +2 | −1 |
| Q2 2025 | 10 | 0 | 26.66M | $118.90M | +2 | −2 |
| Q1 2025 | 7 | -1 | 3.87M | $11.23M | — | −1 |
| Q4 2024 | 8 | 0 | 4.74M | $23.24M | — | — |
| Q3 2024 | 7 | +1 | 2.88M | $13.99M | +1 | — |
| Q2 2024 | 6 | — | 2.25M | $9.69M | — | — |
Who holds it · Q2 2025
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Fidelity (FMR) ✦ | 12.81M | — | $57.14M | 0.0% | n/c | 1 | SEC ↗ |
| 2 | Fidelity (FMR) ✦ | 12.81M | — | $57.14M | 0.0% | n/c | 1 | SEC ↗ |
| 3 | BlackRock ✦ (passive) | 4.08M | — | $18.20M | 0.0% | n/c | 1 | SEC ↗ |
| 4 | BlackRock ✦ (passive) | 4.08M | — | $18.20M | 0.0% | n/c | 1 | SEC ↗ |
| 5 | BlackRock ✦ (passive) | 4.08M | — | $18.20M | 0.0% | n/c | 1 | SEC ↗ |
| 6 | BlackRock ✦ (passive) | 4.08M | — | $18.20M | 0.0% | n/c | 1 | SEC ↗ |
| 7 | BlackRock ✦ (passive) | 4.08M | — | $18.20M | 0.0% | n/c | 1 | SEC ↗ |
| 8 | The Vanguard Group ✦ (passive) | 4.02M | — | $17.94M | 0.0% | n/c | 1 | SEC ↗ |
| 9 | The Vanguard Group ✦ (passive) | 4.02M | — | $17.94M | 0.0% | n/c | 1 | SEC ↗ |
| 10 | The Vanguard Group ✦ (passive) | 4.02M | — | $17.94M | 0.0% | n/c | 1 | SEC ↗ |
| 11 | Marshall Wace ✦ | 2.89M | +56.4% | $12.87M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 12 | Marshall Wace ✦ | 2.89M | +56.4% | $12.87M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 13 | Marshall Wace ✦ | 2.89M | +56.4% | $12.87M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 14 | Geode Capital Management ✦ (passive) | 1.71M | +201.7% | $7.63M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 15 | Geode Capital Management ✦ (passive) | 1.71M | +201.7% | $7.63M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 16 | State Street Global Advisors ✦ (passive) | 830.07K | +319.9% | $3.70M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 17 | Point72 Asset Management ✦ | 211.51K | New | $943,331 | 0.0% | New | 1 | SEC ↗ |
| 18 | Renaissance Technologies ✦ | 52.83K | -86.0% | $235,635 | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 19 | T. Rowe Price ✦ | 33.56K | New | $150,000 | 0.0% | New | 1 | SEC ↗ |
| 20 | Citadel Advisors ✦ | 16.60K | -84.8% | $74,040 | 0.0% | ▼ Trim | 5 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value — the conviction measure. ✦ = curated manager.
New buyers
| Point72 Asset Management | $943,331 | 0.0% |
| T. Rowe Price | $150,000 | 0.0% |
Exited
| Millennium Management | $2.12M | was 0.0% |
| Two Sigma Investments | $123,340 | was 0.0% |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 1 holders, 81.00K shares, $247 reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
Frequently co-owned
What else this security's tracked holders most often hold — shared-ownership counts, not fundamental relationships.
Provenance: Ownership from parsed 13F common-stock positions (tracked universe, comparable sets for changes); insider rows from Forms 3/4/5; stakes from Schedules 13D/13G; every filing links to its original on SEC EDGAR.
Reporting period: Q2 2025 ·
Methodology ·
Get this via the API